文献速递肾血管病与高血压慢性肾脏病血液净化与透析

医院内心肾综合征

Cardiorenal Syndrome in the Hospital.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-01-13

心肾综合征是涉及心脏和肾脏功能障碍的一组复杂双向病理生理通路。因急性失代偿性心力衰竭入院的患者中,高达60%患有慢性肾脏病(定义为eGFR<60 ml/min per 1.73 m²)。慢性肾脏病是急性失代偿性心力衰竭死亡和心血管事件的最强危险因素之一。

要点

  • 因急性失代偿性心力衰竭入院的患者中,高达60%患有慢性肾脏病(eGFR<60 ml/min per 1.73 m²)。
  • 心肾综合征的标志是强烈的钠潴留和利尿剂抵抗,常需联合不同药理靶点的利尿剂并监测尿反应。
  • 低心输出量和心源性休克时增加前向灌注的策略可包括降低后负荷和正性肌力药,最严重病例可用机械循环支持装置。

核心结论

  • 心肾综合征涉及静脉淤血、动脉充盈不足、神经激素激活、炎症和内皮功能障碍等机制。
  • 排除与心肾综合征不同的固有肾脏疾病应获取详细病史、审查纵向eGFR趋势、评估白蛋白尿和蛋白尿、审查尿沉渣和肾脏影像。
  • 心肾综合征的标志是强烈的钠潴留和利尿剂抵抗,常需联合不同药理靶点的利尿剂并监测尿反应以指导治疗升级。
  • 可能需要有创减容方法包括超滤或肾脏替代治疗如腹膜透析,从血流动力学角度常比间歇性血液透析耐受更好。
  • 低心输出量和心源性休克时增加前向灌注的策略可包括降低后负荷和正性肌力药,最严重病例可用机械循环支持装置。

研究设计与样本

  • 原文未报告研究设计。

主要发现

  • 因急性失代偿性心力衰竭入院的患者中,高达60%患有慢性肾脏病(定义为eGFR<60 ml/min per 1.73 m²)。
  • 慢性肾脏病是急性失代偿性心力衰竭死亡和心血管事件的最强危险因素之一。
  • 动脉充盈不足可能导致肾素-血管紧张素-醛固酮系统和交感神经系统激活,导致钠重吸收和血管收缩。
  • 静脉淤血可能也介导并维持这些适应不良通路。
  • 腹膜透析从血流动力学角度常比间歇性血液透析耐受更好。

关键数值与推荐

  • 慢性肾脏病定义为eGFR<60 ml/min per 1.73 m²。
  • 因急性失代偿性心力衰竭入院的患者中高达60%患有慢性肾脏病。

临床怎么用

  • 排除固有肾脏疾病应获取详细病史、审查纵向eGFR趋势、评估白蛋白尿和蛋白尿、审查尿沉渣和肾脏影像。
  • 利尿剂抵抗常需联合不同药理靶点的利尿剂并监测尿反应以指导治疗升级。
  • 有创减容可包括超滤或肾脏替代治疗如腹膜透析。
  • 低心输出量和心源性休克时增加前向灌注的策略可包括降低后负荷和正性肌力药,最严重病例可用机械循环支持装置。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The cardiorenal syndrome refers to a group of complex, bidirectional pathophysiological pathways involving dysfunction in both the heart and kidney. Upward of 60% of patients admitted for acute decompensated heart failure have CKD, as defined by an eGFR of <60 ml/min per 1.73 m 2 . CKD, in turn, is one of the strongest risk factors for mortality and cardiovascular events in acute decompensated heart failure. Although not well understood, the mechanisms in the cardiorenal syndrome include venous congestion, arterial underfilling, neurohormonal activation, inflammation, and endothelial dysfunction. Arterial underfilling may lead to activation of the renin-angiotensin-aldosterone system and sympathetic nervous system, leading to sodium reabsorption and vasoconstriction. Venous congestion likely also mediates and perpetuates these maladaptive pathways. To rule out intrinsic kidney disease that is distinct from the cardiorenal syndrome, one should obtain a careful history, review longitudinal eGFR trends, assess albuminuria and proteinuria, and review the urine sediment and kidney imaging. The hallmark of the cardiorenal syndrome is intense sodium avidity and diuretic resistance, often requiring a combination of diuretics with varying pharmacological targets, and monitoring of urinary response to guide escalations in therapy. Invasive means of decongestion may be required including ultrafiltration or KRT such as peritoneal dialysis, which is often better tolerated from a hemodynamic perspective than intermittent hemodialysis. Strategies for increasing forward perfusion in states of low cardiac output and cardiogenic shock may include afterload reduction and inotropes and, in the most severe cases, mechanical circulatory support devices, many of which have kidney-specific considerations.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. McCallum W, Sarnak MJ. Cardiorenal Syndrome in the Hospital. Clin J Am Soc Nephrol. 2023. PMID: 36787124. doi:10.2215/CJN.0000000000000064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。